AhR Agonists for Psoriasis: A Novel Mechanism for Treatment of PsO
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2023-08/AhR%20Agonists%20for%20Psoriasis%20A%20Novel%20Mechanism%20082223_800x450%20copy%20%282%29.jpg?itok=ZqK7hijp)
Psoriasis is a difficult disease to manage due to a variety of factors including fluctuations in disease severity, limited treatment options, and a limited understanding of the pathogenesis of disease.
Category
- LivDerm
- TME
Format
- Self-study / Enduring
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation